Home LiteratureArticle Details

PMID: 6448851 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Tumor-associated ganglio-N-triosylceramide. Target for antibody-dependent, avidin-mediated drug killing of tumor cells.

The Journal of biological chemistry ·Vol. 255 ·No. 21 ·1980-11-10 ·Pages 10509-16

Urdal DL, Hakomori S

Abstract

暂无摘要

MeSH Terms

Animals Antibiotics, Antineoplastic/pharmacology Antigen-Antibody Complex Avidin/pharmacology Biotin/pharmacology Cell Line Cell Survival/drug effects Cell Transformation, Viral Dactinomycin/pharmacology G(M1) Ganglioside/immunology,physiology Immunodiffusion Kirsten murine sarcoma virus Leukemia L5178/physiopathology Leukemia, Experimental/physiopathology Liposomes Mice Phosphatidylethanolamines/pharmacology Zinostatin/pharmacology

Chemicals

Antibiotics, Antineoplastic Antigen-Antibody Complex Liposomes Phosphatidylethanolamines Avidin Dactinomycin G(M1) Ganglioside Biotin Zinostatin

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Urdal D L

Hakomori S

Article Info

Journal

The Journal of biological chemistry

Abbr.

J Biol Chem

ISSN

0021-9258

Published

1980-11-10

Pages

10509-16

Language

English

Region

United States

NLM ID

2985121R

Subset

Grants

NCI NIH HHS · CA20026 · United States

NIGMS NIH HHS · GM23100 · United States

External Links

PubMed source View journal details

Analysis Services

Tumor-associated ganglio-N-triosylceramide. Target for antibody-dependent, avidin-mediated drug killing of tumor cells.

Contact

WeChat Official Account